Navigation Links
Systematic Review of Patient-Reported Outcomes (PROs) Can Reduce Cost of Cancer Care
Date:4/28/2008

Supportive Oncology Services, Inc. leads PRO collection in community

oncology

MEMPHIS, Tenn., April 28 /PRNewswire/ -- Supportive Oncology Services (SOS), Inc. a research-based health-outcomes company specializing in oncology, issued the following statement today regarding the impact of Patient-Reported Outcomes (PROs) in the cancer community.

"Appropriate use of PRO information in the community oncology setting and timely intervention can significantly reduce the cost of patient care," according to Steve Coplon, CEO. "Avoidance of hospitalization dramatically reduces costs to treat cancer and improve health outcomes. For example, in our area an acute case requiring hospitalization for febrile neutropenia costs approximately $28,000 per event; hospitalization for anemia costs $23,000 per event; and hospitalization for severe nausea/vomiting costs $13,000 per event."

Dr. Kurt Tauer, Senior Partner with The West Clinic-Memphis states, "Conservatively, we keep over 75 patients per week out of the hospital and emergency room. Many of these avoided admissions are a direct result of patient self-reported assessments we collect via the PACE System(TM) e/Tablet. This crucial information enables our physicians to make appropriate interventions. We hear similar results from other community-based cancer clinics across the country."

The value of PROs in caring for the patient and potentially predicting and avoiding negative outcomes has been recently recognized by the Institute of Medicine (Cancer Care for the Whole Patient, 2008) and research published in the Journal of Clinical Oncology (J Clin Oncol 26:1355-1363). Additionally, Duke University's Cancer Program recognized the importance of PROs and implemented The PACE System(TM) in research projects across its Oncology Supportive Care department.

In April 2008, SOS announced it had accrued over one million cancer patient self-reported assessments using the PACE(TM) electronic e/Tablet system. Aggregated data from these self-assessments provides a rich resource for oncology research.

"All formal studies of the PACE(TM) System have proven that a more thorough and frequent assessment of the patient occurs when PROs are gathered by e/Tablets," affirms Edward J. Stepanski, PhD, Chief Operating Officer for SOS. "There is increasing recognition that PROs are the most accurate measure of symptoms and side effects. Thus, when clinicians routinely gather more, higher quality data and take action, good things happen for the patient."

For additional information contact Liz Conway, Director of Marketing and Corporate Services, 901-259-0878 or visit http://www.SupportiveOncologyServices.com.

About Supportive Oncology Services, Inc. (SOS)

Supportive Oncology Services, Inc. (SOS), an information and outcomes company, works closely with community oncology practices and oncology academic centers which provide treatment for over a half million cancer patients across the US. SOS also collaborates with bio-technology and pharmaceutical companies, the financial industry, payers, and other cancer-related industry leaders on diverse clinical, financial, and operational initiatives. By continuously offering improvements, measuring results and providing value, SOS helps define and improve the quality of cancer care provided.

Liz Conway

901-435-5570

Cell: 901-486-4872

lconway@sosacorn.com

Deborah D. Coble

901-683-0055 x1312

Cell: 901-831-1010

dcoble@sosacorn.com


'/>"/>
SOURCE Supportive Oncology Services, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. The Diabetes Educator publishes systematic reviews for diabetes management
2. Methadone and systematic follow-up: the best solution for managing chronic pain
3. SEIU RN Dian Palmer Calls on AFL-CIO Head John Sweeney to Review Video From Dearborn Protest, Retract Statement Accepting CNA Distortions
4. Review Urges Aggressive MRSA Screening for Health Workers
5. ACC Calls on FDA to Update Review of Bisphenol A
6. Press Preview to Unveil Miracle Manny
7. PreMD Provides Update on FDA Review
8. Neuroscience Peer Review Consortium announces increased journal participation
9. ExoSeal vascular plug gets good reviews in ECLIPSE study
10. Symmetry Medical Delays 10-K Filing to Complete Review
11. Review of group-based cancer trials reveals flaws in studies design and analysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... ... 2016 , ... Comfort Keepers® of San Diego, CA is excited to announce ... program to drive cancer patients to and from their cancer treatments. Comfort Keepers ... of life and ongoing independence. Getting to and from medical treatments is one ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
(Date:6/24/2016)... , June 24, 2016  Global Blood Therapeutics, ... company developing novel therapeutics for the treatment of ... announced the closing of its previously announced underwritten ... at the public offering price of $18.75 per ... were offered by GBT. GBT estimates net proceeds ...
(Date:6/24/2016)... The Academy of Managed Care Pharmacy (AMCP) ... would allow biopharmaceutical companies to more easily share health ... and coverage decisions, a move that addresses the growing ... The recommendations address restrictions in the sharing of ... label, a prohibition that hinders decision makers from accessing ...
Breaking Medicine Technology: